Key Metrics
CiteScore 

5.2
Impact Factor 

< 5
SJR 

Q2Pharmacology (medical)

SNIP 

1.02
Recommended pre-submission checks
Powered by 

Topics Covered on Clinical Drug Investigation
Clinical Drug Investigation Journal Specifications
| Overview | |
| Publisher | ADIS INT LTD |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1995 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Clinical Drug Investigation ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations

Recently Published Papers in Clinical Drug Investigation
Treatment of Non-severe COVID-19 with Molnupiravir: A Systematic Review with Meta-analysis and Trial Sequential Analysis of the Evidence from Randomized Controlled Trials.
- 25 Nov 2025
- Clinical drug investigation
Acknowledgement to Referees and the Editorial Board.
- 17 Nov 2025
- Clinical drug investigation
Comparative Pharmacokinetic Assessment of Once-Daily Extended-Release and Twice-Daily Amantadine Formulations in Healthy Male Subjects Under Fasting Conditions.
- 12 Nov 2025
- Clinical drug investigation
Bumetanide Nasal Spray: First Approval.
- 12 Nov 2025
- Clinical drug investigation
CT-P39: An Omalizumab Biosimilar.
- 12 Nov 2025
- Clinical drug investigation
Budget Impact of Preoperative Anemia Management, the First Pillar of Patient Blood Management, on the Romanian Healthcare System.
- 8 Nov 2025
- Clinical drug investigation
Treatment of Non-severe COVID-19 with Molnupiravir: A Systematic Review with Meta-analysis and Trial Sequential Analysis of the Evidence from Randomized Controlled Trials.
- 25 Nov 2025
- Clinical drug investigation
Acknowledgement to Referees and the Editorial Board.
- 17 Nov 2025
- Clinical drug investigation
Comparative Pharmacokinetic Assessment of Once-Daily Extended-Release and Twice-Daily Amantadine Formulations in Healthy Male Subjects Under Fasting Conditions.
- 12 Nov 2025
- Clinical drug investigation
Bumetanide Nasal Spray: First Approval.
- 12 Nov 2025
- Clinical drug investigation
CT-P39: An Omalizumab Biosimilar.
- 12 Nov 2025
- Clinical drug investigation
Budget Impact of Preoperative Anemia Management, the First Pillar of Patient Blood Management, on the Romanian Healthcare System.
- 8 Nov 2025
- Clinical drug investigation